Kathryn J. Collier

Insider Reports History

Entity
Individual
Location
C/O Regulus Therapeutics Inc., 10614 Science Center Drive, San Diego, CA
Signature
Christopher Aker, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathryn J. Collier:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Director Common Stock 6.74K $12.3K $1.82 Jul 25, 2024 Direct
Regulus Therapeutics Inc. Director Stock Option (Right to Buy) 60K May 20, 2024 Direct

Insider Reports Filed by Kathryn J. Collier

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGLS Regulus Therapeutics Inc. Jul 25, 2024 1 $7.28K 4 Jul 29, 2024 Director
RGLS Regulus Therapeutics Inc. May 20, 2024 1 $0 4 May 21, 2024 Director
RGLS Regulus Therapeutics Inc. May 16, 2024 1 $0 4 May 17, 2024 Director
RGLS Regulus Therapeutics Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 Director
RGLS Regulus Therapeutics Inc. Jun 13, 2023 1 $0 4 Jun 13, 2023 Director
RGLS Regulus Therapeutics Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
RGLS Regulus Therapeutics Inc. Jun 14, 2021 1 $0 4 Jun 15, 2021 Director